AUGUSTUS - Apixaban versus Vitamin K Antagonist in Atrial Fibrillation ACS / PCI
Project Description
An open-label, 2 x 2 factorial, randomized controlled, clinical trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. aspirin placebo in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention.
Project Duration
2015 - 2015
Project Lead
Dr. Denis Xavier; Dr. Atiya Faruqui
Authors
Dr Denis Xavier
Project Status
completed
Project Type
BMS / Pfizer